MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Laboratory Corp of America Holdings

Closed

SectorHealthcare

285.46 0.77

Overview

Share price change

24h

Current

Min

285.07

Max

286.13

Key metrics

By Trading Economics

Income

25M

238M

Sales

182M

3.5B

P/E

Sector Avg

30.501

36.442

Dividend yield

1.04

Profit margin

6.756

Employees

70,000

EBITDA

34M

532M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+8.33% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.04%

3.00%

Next Earnings

28 paź 2025

Next Dividend date

11 gru 2025

Next Ex Dividend date

26 lis 2025

Market Stats

By TradingEconomics

Market Cap

2.6B

23B

Previous open

284.69

Previous close

285.46

Laboratory Corp of America Holdings Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 maj 2025, 18:12 UTC

Earnings

Netflix Is Eating Disney's Lunch. How to Bring Back the Magic. -- Barrons.com

Peer Comparison

Price change

Laboratory Corp of America Holdings Forecast

Price Target

By TipRanks

8.33% upside

12 Months Forecast

Average 309.75 USD  8.33%

High 342 USD

Low 280 USD

Based on 13 Wall Street analysts offering 12 month price targets forLaboratory Corp of America Holdings - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

11

Buy

2

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Laboratory Corp of America Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
help-icon Live chat